On Wednesday, February 9, 2022, Alyse Bedell, PhD, and David T. Rubin, MD, provided new insights and answered questions for patients living with Crohn’s disease and ulcerative colitis in a webinar co-sponsored by the GI Research Foundation. Both presentations are now available online.
Research has led to many new therapies for Crohn’s disease and ulcerative colitis in recent years, providing additional treatment options to help patients reach remission. But the advent of new therapies also raises questions about which treatments are most effective for different kinds of patients and disease states. Dr. Rubin reviewed the most recent science about these treatment options, and how physicians decide among medical therapies for their patients.
Patients and physicians sometimes overlook the impact of social and emotional well-being on the treatment of Crohn’s disease and ulcerative colitis. Dr. Bedell offered an overview of the mind-body connection and coping strategies for patients living with IBD. In this webinar, Dr. Bedell discussed the biopsychosocial model for treating patients, which helps explain how biological and social factors impact the development of disease. She reviewed the specific concerns IBD patients may have with regard to their mental health and offered recommendations for helpful therapeutic techniques.
David T. Rubin, MD is the Joseph B. Kirsner Professor of Medicine; Chief of the Section of Gastroenterology, Hepatology and Nutrition; and Co-Director of the Digestive Diseases Center at the University of Chicago Medicine. Alyse Bedell, PhD, is an assistant professor of psychology and GI psychologist at the University of Chicago Medicine Digestive Diseases Center.